Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer
2579.1000 7.10 (0.28%)
NSE Sep 12, 2025 15:31 PM
Volume: 58,267
 

logo
Ajanta Pharma Ltd.
01 Aug 2018
2579.10
0.28%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 8% YoY to | 511.0 crore (I-direct estimate: | 473.6 crore) mainly due to 24.5% YoY growth in domestic formulations to | 178.0 crore (I-direct estimate: | 175.0 crore) and 34.4% growth in Asia business to | 129 crore (I-direct estimate: | 134 crore) EBITDA margins improved 320 bps YoY to 30.8% (I-direct estimate: 25.8%) mainly due to strong gross margins and lower other expenditure. EBITDA grew 20.5% YoY to | 157.5 crore...
Promoters pledged 1.51% of shares in last quarter. Total pledge stands at 14.12% of promoter holdings
More from Ajanta Pharma Ltd.
Recommended